<p>A) MPS I mice treated from 6 to 8 months with 1.2mg laronidase/kg every two weeks (n = 10). Urine was collected 1 day post injections. **P<0.01, ANOVA and Tukey. B) Comparison between urinary GAG from 8-month old wild-type (normal, n = 4), MPS I (n = 3) and treated MPS I mice (ERT 6–8mo, n = 10), 1 day after last injection. Treated mice achieve normal GAG level (dotted lines) as soon as the second injection. C) Tissue GAG from 8-month old normal (n = 4/5), MPS I (n = 5–6) and ERT 6–8mo (n = 10) mice collected two weeks after last injection. #P<0.05, Kruskal-Wallis and Mann-Whitney <i>post hoc</i>. ***P<0.001 ANOVA and Tukey <i>post hoc</i>.</p
<p>Mice were sacrificed on day 28 and sera prepared from 16 hour fasted mice housed in metabolic cag...
<p>Shown is the relative GAG per DNA content of chondrocytes (A) and MSCs (B), with day 0 being the ...
Mucopolysaccharidosis type I (MPS I) is a progressive disorder caused by deficiency of α- L-iduronid...
<p>(<b>A</b>) 24-hour micturition frequencies were significantly higher 5 weeks after immunization o...
<p>Six and half months old female NZB/W F<sub>1</sub> mice were orally treated with vehicle (saline)...
BACKGROUND: Hunter syndrome, mucopolysaccharidosis type II (MPS II), is a X-linked inherited disorde...
Mucopolysaccharidosis type I (MPS I) is a progressive disorder caused by deficiency of α-L-iduronida...
<p>(A) Body weight losses, (B) stool and histological score, (C) histology of colonic sections and (...
<p>Changes in voiding habits after a single sub-noxious dose of intravesical LPS in URO-MCP-1 mice.<...
<div><p>Mucopolysaccharidosis type I (MPS I) is a progressive disorder caused by deficiency of α-L-i...
Mice were inoculated through the urethra with either MMH594 or MMH594b (Δesp). At 1, 3, or 5 days af...
<p>(A) All animals (starting at 12 weeks of age, 6 per group) were placed in metabolic cages for uri...
<p>A, B, C: data describing the micturition pattern: first voiding latency (A), urine volume (B) and...
<p>Panels A and B illustrate the time course of licking after intraplantar injection of 0.01% capsai...
<p>BALB/c mice were given 500 pfu of PR8 virus in 10 µl by the intranasal route to establish a local...
<p>Mice were sacrificed on day 28 and sera prepared from 16 hour fasted mice housed in metabolic cag...
<p>Shown is the relative GAG per DNA content of chondrocytes (A) and MSCs (B), with day 0 being the ...
Mucopolysaccharidosis type I (MPS I) is a progressive disorder caused by deficiency of α- L-iduronid...
<p>(<b>A</b>) 24-hour micturition frequencies were significantly higher 5 weeks after immunization o...
<p>Six and half months old female NZB/W F<sub>1</sub> mice were orally treated with vehicle (saline)...
BACKGROUND: Hunter syndrome, mucopolysaccharidosis type II (MPS II), is a X-linked inherited disorde...
Mucopolysaccharidosis type I (MPS I) is a progressive disorder caused by deficiency of α-L-iduronida...
<p>(A) Body weight losses, (B) stool and histological score, (C) histology of colonic sections and (...
<p>Changes in voiding habits after a single sub-noxious dose of intravesical LPS in URO-MCP-1 mice.<...
<div><p>Mucopolysaccharidosis type I (MPS I) is a progressive disorder caused by deficiency of α-L-i...
Mice were inoculated through the urethra with either MMH594 or MMH594b (Δesp). At 1, 3, or 5 days af...
<p>(A) All animals (starting at 12 weeks of age, 6 per group) were placed in metabolic cages for uri...
<p>A, B, C: data describing the micturition pattern: first voiding latency (A), urine volume (B) and...
<p>Panels A and B illustrate the time course of licking after intraplantar injection of 0.01% capsai...
<p>BALB/c mice were given 500 pfu of PR8 virus in 10 µl by the intranasal route to establish a local...
<p>Mice were sacrificed on day 28 and sera prepared from 16 hour fasted mice housed in metabolic cag...
<p>Shown is the relative GAG per DNA content of chondrocytes (A) and MSCs (B), with day 0 being the ...
Mucopolysaccharidosis type I (MPS I) is a progressive disorder caused by deficiency of α- L-iduronid...